This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (18)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Bin T. Teh, MD; John McArdle, MD, FRACPA; Venkateswaran Parameswaran, PhD; Rubin David; Catharina Larsson, MD, PhD; Joseph Shepherd, MD, FRACS

Arch Surg. 1996;131(11):1230-1232.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant disease characterized by neoplasia involving the parathyroid glands, the endocrine pancreas, the duodenum, and the anterior pituitary. The most commonly involved gland is the parathyroid gland, which has been found to be abnormal in 90% to 95% of all patients with MEN 1. The disease process is invariably multiglandular and histologically described as either hyperplasia or multiple adenoma, although the histological distinction between the 2 entities remains difficult and controversial.¹ The prevalence of MEN 1 is approximately 0.002 in 100, whereas the prevalence of sporadic primary hyperparathyroidism due to a solitary adenoma is estimated to be as high as 1 in 100.^2,3 We report herein the first case of sporadic primary hyperparathyroidism in the setting of MEN 1 based on clinical, biochemical, pathological, and genetic studies.

REPORT OF A CASE

In 1986, we examined a 53-year-old woman . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Molecular Medicine, Karolinska Hospital, Sweden (Drs Teh and Larsson); and Royal Hobart Hospital, Tasmania, Australia (Drs McArdle, Parameswaran, and Shepherd and Mr David).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?